Andrea (Andy) Coville is CEO, Brodeur Partners. For 25 years, Andy has developed and executed high-performing global communications campaigns for organizations in the business-to-business, consumer products and health care markets. Her agency’s extensive client roster has included Eaton Vance, Fidelity, MasterCard, Banc Itau, Sanofi, FM Global, Corning, the American Cancer Society (ACS), GreenLight Biosciences, Canivate, IBM, Phillips, RIM (Blackberry), The Trustees, Blackbird, Bio, Vertex, 3M and GE Plastics.
In addition to overseeing Brodeur’s strategic direction and operations, Andy specializes in helping organizations achieve relevance, an elevated brand state that fully engages the market’s emotions, senses and community-minded impulses.
Andy joined Brodeur in 1986 and became partner in 1990. After being appointed CEO in 1999, she took responsibility for the agency’s global footprint. She has since diversified Brodeur Partners from a public relations firm specializing in technology to a multidisciplinary communications agency focusing on full-service communications, digital strategies, social change and business consulting. She has overseen Brodeur’s health care practice since its inception with particular emphasis on medical device and bio/pharma clients.
Andy has led the creative planning process for three global movements, specifically around cancer, hepatitis C and entrepreneurship. She has also developed a consulting practice focusing on leadership for women. She frequently leads workshops on social media and brand transformation. She is the author of Relevance: The Power to Change Minds and Behavior and Stay Ahead of the Competition.
